Search results for "Rigaku Analytical Devices"
Selected Filters:
Thermo Scientific Gemini Analyzer enhances identification of low dose concentration of illegal substances
The analyzer with LowDoseID for narcotics analysis eliminates concentration limitations from testing process
BioDot accelerates manufacturing to help customers meet global COVID-19 testing demand
Automated “lateral flow” dispensing technology is vital step in rapid point-of-care antibody test production
Unlock the future of PFAS detection with high-resolution mass spectrometry
Discover how Waters' HRMS innovations are enhancing the accuracy and scope of PFAS detection and analysis
Exclusive Preview of the C96 HT Extraction System Displayed at Biotechnica
What's New in Environmental Science?
Cancer Research Video Highlights: Our Top Interviews from AACR 2019
We look back at the 2019 American Association for Cancer Research (AACR) annual meeting and the technology set to propel cancer research
Avacta and Leeds University Awarded £3.8m Medical Research Council Funding to Develop New Diagnostic Tests
Avacta collaborates to develop rapid tests to differentiate between viral and bacterial infections and to differentiate bacterial strains
Latest Gemini technology for ultimate microscopic characterization of challenging samples
Watch this on-demand webinar to find out how the Gemini technology from ZEISS addresses challenging microscopy samples
Kaluza C Analysis Software
Beckman Coulter Life SciencesPurpose-built for clinical laboratories, Kaluza C Flow Cytometry Analysis Software helps you turn critical data into meaningful patient reports.
SAFE® 96/48/24-Channel Capper
LVL Technologies GmbH & Co. KGFully automated 96/48/24 channel premium capper/decapper for SAFE® Screw Caps
Study highlights the importance of bonding between young mental health patients and nurses
Therapeutic relationships can help improve outcomes for mental health patients
Maravai LifeSciences expands CleanCap mRNA capping capacity and new plasmid DNA manufacturing
Second manufacturing expansion will help meet global demand for research, clinical and GMP grade raw materials as well as research and clinical-grade APIs to include mRNA, self-amplifying RNA and plasmid DNA